Phase III clinical trial results at the 48th Union World Conference on Lung Health: Implications for the field
Preliminary results from two phase III drug-resistant TB (DR-TB) clinical trials were presented at the 48th Union World Conference on Lung Health: stage 1 of the STREAM trial and the Otsuka 213 delamanid trial.
DR-TB STAT has released a statement reviewing the findings of
these studies as presented at the Conference and reviewed later
with the study investigators, and discussing possible
implications for decisions made at country level, while formal
WHO review and recommendations are pending.
The
statement can be accessed
here.
